CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing innovative gold-based compounds that can be activated by light to treat cancer. These compounds aim to enhance the effectiveness of chemotherapy while minimizing side effects, and they also serve as imaging agents for better treatment guidance.
The use of light to activate anticancer prodrugs is nowadays a reality in clinics around the world.
Photodynamic therapy is an effective treatment for the localised destruction of cancer cells in a range of tissues and organs.
Triggering the antiproliferative activity of chemotherapy agents with spatial and temporal control offers the advantage of reducing side effects and resistance.
On the bases of the great success of metal-based drugs (e.g. cisplatin and its derivatives), photoactivatable me…
FUNDACION DONOSTIA INTERNATIONAL PHYSICS CENTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
